CR10018A - - Google Patents

Info

Publication number
CR10018A
CR10018A CR10018A CR10018A CR10018A CR 10018 A CR10018 A CR 10018A CR 10018 A CR10018 A CR 10018A CR 10018 A CR10018 A CR 10018A CR 10018 A CR10018 A CR 10018A
Authority
CR
Costa Rica
Application number
CR10018A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CR10018A publication Critical patent/CR10018A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CR10018A 2005-12-01 2008-05-26 CR10018A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20050116567 2005-12-01

Publications (1)

Publication Number Publication Date
CR10018A true CR10018A (pt) 2008-09-02

Family

ID=38092428

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10018A CR10018A (pt) 2005-12-01 2008-05-26

Country Status (14)

Country Link
US (1) US7776873B2 (pt)
EP (1) EP1954279A4 (pt)
JP (1) JP5207974B2 (pt)
KR (1) KR100805660B1 (pt)
CN (2) CN102309490A (pt)
AU (1) AU2006321471B2 (pt)
BR (1) BRPI0619081A2 (pt)
CA (1) CA2631068C (pt)
CR (1) CR10018A (pt)
EC (1) ECSP088545A (pt)
IL (1) IL191680A0 (pt)
MY (1) MY145406A (pt)
WO (1) WO2007064128A1 (pt)
ZA (1) ZA200805747B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0720472A2 (pt) 2006-12-22 2014-01-14 Yuhan Corp Dispersão sólida contendo revaprazan e processo para a preparação da mesma
KR101605063B1 (ko) 2009-07-09 2016-03-21 라퀄리아 파마 인코포레이티드 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제
KR101730865B1 (ko) * 2011-02-11 2017-04-27 주식회사유한양행 레바프라잔-함유 나노입자를 포함하는 경구투여용 약학 조성물 및 그의 제조방법
KR101739818B1 (ko) * 2011-05-20 2017-05-26 주식회사유한양행 레바프라잔 또는 그의 염을 함유하는 현탁액 형태의 경구투여용 약학 조성물
MX386414B (es) 2015-07-30 2025-03-18 Takeda Pharmaceuticals Co Tableta.
CN105998688A (zh) * 2016-06-22 2016-10-12 郑亮 一种胃粘膜损伤的抑制方法
KR20180107341A (ko) * 2017-03-16 2018-10-02 차의과학대학교 산학협력단 칼륨 경쟁적 위산분비억제제를 유효성분을 함유하는 장 누수 증후군 치료 및 예방용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
JP2896532B2 (ja) * 1994-08-13 1999-05-31 ユーハン コーポレーション 新規なピリミジン誘導体およびその製造方法
CN1190427C (zh) * 1996-05-04 2005-02-23 株式会社柳韩洋行 制备嘧啶衍生物的方法
EP0940400A4 (en) * 1996-10-25 2002-10-02 Mitsubishi Pharma Corp HETEROCYCLIC AMID COMPOUNDS AND THEIR MEDICAL APPLICATION
WO1998018784A1 (en) 1996-10-29 1998-05-07 Yuhan Corporation Process for preparation of pyrimidine derivatives
GB0110338D0 (en) * 2001-04-27 2001-06-20 Sb Pharmco Inc Novel processes
US8206741B2 (en) * 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs

Also Published As

Publication number Publication date
CN101316594A (zh) 2008-12-03
KR20070057663A (ko) 2007-06-07
EP1954279A4 (en) 2009-06-03
ZA200805747B (en) 2009-11-25
IL191680A0 (en) 2009-08-03
US7776873B2 (en) 2010-08-17
AU2006321471A1 (en) 2007-06-07
CA2631068C (en) 2011-01-11
CN102309490A (zh) 2012-01-11
BRPI0619081A2 (pt) 2011-09-20
AU2006321471B2 (en) 2010-07-29
MY145406A (en) 2012-02-15
JP5207974B2 (ja) 2013-06-12
EP1954279A1 (en) 2008-08-13
CN101316594B (zh) 2012-07-25
JP2009517462A (ja) 2009-04-30
US20070129391A1 (en) 2007-06-07
WO2007064128A1 (en) 2007-06-07
HK1123507A1 (en) 2009-06-19
CA2631068A1 (en) 2007-06-07
KR100805660B1 (ko) 2008-02-21
ECSP088545A (es) 2008-08-29

Similar Documents

Publication Publication Date Title
BE2025C533I2 (pt)
BE2024C510I2 (pt)
BE2023C529I2 (pt)
BE2021C552I2 (pt)
BE2021C557I2 (pt)
BE2021C531I2 (pt)
BE2021C524I2 (pt)
BE2021C519I2 (pt)
BE2021C513I2 (pt)
BE2020C531I2 (pt)
BE2020C511I2 (pt)
BE2020C508I2 (pt)
BE2020C004I2 (pt)
BE2019C521I2 (pt)
BE2019C503I2 (pt)
BE2018C037I2 (pt)
BE2018C019I2 (pt)
BE2018C016I2 (pt)
BE2017C028I2 (pt)
BE2019C533I2 (pt)
BE2016C022I2 (pt)
BE2014C057I2 (pt)
BRPI0601358B8 (pt) Aplicador de clipe cirúrgico
BRPI0601402B8 (pt) Aplicador de grampos cirúrgicos
BR122017004707A2 (pt)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)